1 / 92

Bacteria Pathogenicity

Bacteria Pathogenicity. Ability to Cause Infection. Infectious Diseases. Encounter-bug meets host (reservoir) Bug adheres to host Entry-bug enters host Multiplication- bug multiplies in host. Infectious Diseases. Damage to host Virulence of bug or host response

albert
Download Presentation

Bacteria Pathogenicity

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Bacteria Pathogenicity Ability to Cause Infection

  2. Infectious Diseases • Encounter-bug meets host (reservoir) • Bug adheres to host • Entry-bug enters host • Multiplication- bug multiplies in host

  3. Infectious Diseases • Damage to host • Virulence of bug or host response • Outcome- bug or host wins or • Coexist- chronic infection

  4. Reservoir • Exposure to microbe • Humans • Animals • Environment

  5. Virulence Factors • Enhance colonization & growth • # of cells required to establish infection • Measure of pathogenicity

  6. Adherence (Virulence Factor) • Attachment to host cells • Adhesins on pathogen (proteins) • Bind to complimentary surface receptor

  7. Adherence • Prevent infection • Influenza changes adhesions over time • Neisseria gonorrhoeae -variety of adhesions

  8. Portals of Entry • Mucous membranes • Respiratory • GI • Genitourinary • Conjunctiva

  9. Portals of Entry • Skin • Bugs have preferred portal • C. tetani spores in soil --- anaerobic wound

  10. Inoculum • Number of microbes-dose • Greater dose, more chance infection will occur • ID50 or LD50 expresses virulence • Infectious or lethal dose for 50% of population • LD50 used for toxins

  11. ID50 • ID50 for B.anthracis via skin is 10 to 50 endospores • Via which route is infection more likely? • Via which route is infection more lethal?

  12. Invasins • Adherence of microbe to surface • Activates factors that let microbe in-penetration • Microbes produce invasins (proteins) • Endocytosis

  13. Colonization • Requires multiplication • Compete with normal flora for space & nutrients

  14. Colonization • Overcome local host defenses • IgA (mucosal surfaces) • Avoid IgA • Rapid turnover of fimbriae/pili • Antigenic variation in type of pili • IgA proteases (enzymes) destroy IgA

  15. Multiplication • Need Fe to multiply • Most is bound in host • Have own iron-binding molecules that compete for Fe-siderophores • \

  16. Avoid Phagocytosis • Avoid recognition & attachment • Capsule • Impairs phagocytosis DT negative charges • Produce antibodies to capsule • \

  17. Avoiding Phagocytosis • Components of cell wall –virulence • Mycolic acids in M. tuberculosis

  18. Surviving Within Phagocyte • Escape from phagosome, vesicle, before fuses with lysosome • Prevent fusion with lysosome • Grow inside phagocyte protected from host

  19. Tuberculosis • Ancient disease • 1/3 of world population infected • 8 million develop active TB each year • 2 million die each year • AIDs increases activation of latent TB

  20. Tuberculosis • Dependent upon virulence of strain & host resistance • Produces cell mediated immunity which prevents active disease in many people • Multi drug resistance has developed

  21. S & S of Pulmonary TB • Chronic disease • Progressive weight loss • Night sweats • Chronic cough • Hemoptysis

  22. Mycobacterium tuberculosis • Acid fast bacillus (AFB) • Resistant to drying • Aerobic, slow growth • Airborne transmission

  23. Mycobacterium tuberculosis • Inhale airborne droplets • Ingested by alveolar macrophages • Multiply in macrophages even with ongoing immune response

  24. TB Response • Host immune response-delayed type hypersensitivity reaction • Tissue damage DT Inflammatory response

  25. TB Conversion • TST skin reaction is positive • Occurs within 24 – 48 hours after exposure to TB antigens • Purified protein derivative of bacillus • Cell mediated immunity • Sensitized T cells react with proteins

  26. QuantiferonGold • Blood test • Detects interferon gamma

  27. How to Confirm Diagnosis • Sputum cultures for AFB smear & culture • Chest xray

  28. Pathogenesis • LTBI (latent TB infection) • Immune defenses contain organism • Formation of tubercle • TB converter • No S&S of disease

  29. Active Disease • Low resistance • Disease not controlled • Cytokines damage lung • Acute pulmonary infection • Can spread & cause death

  30. TB Outcomes • Primary infection- positive skin test • 90% immune system controls infection via cellular immunity • TB germs isolated within tubercles( Activated macrophages)

  31. TB Outcomes • 10% progressive primary infection-not controlled • Illness or death if not treated • Cavities in lungs • Spread throughout body

  32. Secondary or Reactivation Infection • Reinfection-2nd exposure or • Bacteria escape immune system-reactivation • Activated macrophages release cytokines • Delayed hypersensitivity reaction

  33. Prevention of Transmission • Negative pressure rooms • Respirator masks-fit tested • Admit staff aware of symptoms of TB • Yearly TST of staff • Conversions treated with 6-9 months of INH

  34. Treatment • INH for LTBI or TB conversion • TB disease-active TB • 4 drugs till drug sensitivities return • DOT • 9- 12 months of treatment • Slow growing • Impedes abx entering cell wall

  35. Resistant TB • MDR TB • Resistant to INH, & 1 other TB drug • XDR TB • Resistant to all 1st line drugs • Use 2nd line drugs for several years • Often leads to death • DT improper treatment

  36. BCG • Live culture of M. bovis • Attenuated strain • Used in other countries to protect children from miliary disease • Can cause positive reaction on TST

  37. Latent vs Active • Latent TB • Infected but no S&S • Not infectious • Active TB • S&S of disease • Infectious if pulmonary TB

  38. Leprosy • Hanson’s disease- discovered in 1873 • Seen in tropics and underserved countries • U.S.-150 new cases per year

  39. Leprosy • Infection of nervous system • Infects the peripheral nerves within skin • 2 forms of disease dependent upon immune response

  40. M. leprae • Tuberculoid form • Regions of skin, lost sensation surrounded by nodules • Lose pigmentation • Causes strong cell mediated response • Activated macrophages keep microbe under control

  41. Lepromatous Form • Weak immune response & microbe spreads • Skin & nerve cells infected • Shed large #s in nasal secretions and oozing sores-more infectious

  42. Invasion via Enzymes • Exoenzymes- excreted to outside • Coagulases-clot fibrinogen in blood

  43. Kinases • Breakdown fibrin • Produced by strep • Invades tissues & spreads • Used to isolate infections

  44. Enzymes • Hyaluronidases – hydrolyzes hyaluronic acid (polysaccharide) • IgA proteases • Destroys IgA antibodies in secretions

  45. Enzymes • Leukocidins • Kill neutrophils • Hemolysins-staph & strep • Dissolve RBCs • Able to obtain Fe

  46. Invasion via Toxins • Toxins • Poisonous substances damage tissues • Cause shock, fever, inhibit protein synthesis • Two types • Exotoxins • Endotoxins

  47. Exotoxins • Produced inside cell • Mostly proteins, kill in low concentrations • Mainly gram positive • Gene on plasmids or phages • Not bacterial genes

  48. Exotoxins • Destroy part of cell or inhibit metabolic processes • Specific for each exotoxin • Toxin responsible for S &S of disease

  49. Exotoxins • Antitoxins • Antibodies to toxin • Toxoid • Inactivated exotoxin • Use to induce immunity to toxins • Vaccines

  50. A-B Toxins • 2 parts-polypeptides • A-active or enzyme component • B-binding component • B binds toxin to host cell • A-B toxin enters • Components separate & A kills host • Disrupts protein synthesis

More Related